DFFN Historical Earnings image   This DFFN historical earnings page last updated 8/14/2023
DFFN Historical Revenue
PeriodHistorical Earnings DateGAAP
Q2 20238/8/2023NA
Q1 20235/15/2023NA
Q4 20223/24/2023NA
Q3 202211/14/2022NA
Q2 20228/11/2022NA
Q1 20225/12/2022NA
Q4 20213/18/2022NA
Q3 202111/10/2021NA
Q2 20218/11/2021NA
Q1 20215/7/2021NA
Q4 20203/17/2021NA
Q3 202011/12/2020NA
Q2 20208/10/2020NA
Q1 20205/11/2020NA
Q4 20193/17/2020NA
Q3 201911/11/2019NA
Q2 20198/8/2019NA
Q1 20195/9/2019NA
Q4 20183/20/2019NA
Q3 201811/14/2018NA
DFFN Historical Earnings EPS
PeriodHistorical Earnings DateGAAP
Q2 20238/8/2023-1.040
Q1 20235/15/2023-1.950
Q4 20223/24/2023-2.000
Q3 202211/14/2022-1.370
Q2 20228/11/2022-2.060
Q1 20225/12/2022-2.220
Q4 20213/18/2022-1.500
Q3 202111/10/2021-2.000
Q2 20218/11/2021-2.000
Q1 20215/7/2021-3.000
Q4 20203/17/2021-3.000
Q3 202011/12/2020-3.500
Q2 20208/10/2020-5.000
Q1 20205/11/2020-3.500
Q4 20193/17/202012.500
Q3 201911/11/2019-30.000
Q2 20198/8/2019-31.500
Q1 20195/9/2019-40.500
Q4 20183/20/2019-3.000
Q3 201811/14/2018-6.500
Quotes delayed 20 minutes

Email EnvelopeFree DFFN Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Diffusion Pharmaceuticals (DFFN) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

DGX Historical Earnings
DHR Historical Earnings
DICE Historical Earnings
DMTK Historical Earnings
DNAY Historical Earnings
DNLI Historical Earnings
DOMH Historical Earnings
DRNA Historical Earnings
DRRX Historical Earnings
DSGN Historical Earnings
What was the record high DFFN historical earnings result?
In terms of earnings or revenue, what is the best DFFN historical earnings result that Diffusion Pharmaceuticals has ever posted, and when?

✔️Accepted answer: Within our data set, the highest DFFN historical earnings result was set in Q4 2019, when Diffusion Pharmaceuticals posted results of 12.500/share. The most successful revenue quarter within our data set was Q2 2023 when Diffusion Pharmaceuticals reported revenue of NA.

What was the lowest Diffusion Pharmaceuticals historical earnings result?
In terms of top line revenue or bottom line earnings per share, what was the lowest DFFN has reported, and when?

✔️Accepted answer: Within our data set, the lowest DFFN historical earnings result was set in Q1 2019, when Diffusion Pharmaceuticals posted results of -40.500/share. The smallest revenue quarter within our data set was Q2 2023 when Diffusion Pharmaceuticals reported revenue of NA.

On this page we presented the DFFN historical earnings date information for Diffusion Pharmaceuticals. Reviewing that DFFN Historical Earnings for the company, we see that the highest historical earnings result in our data set was in Q4 2019, when DFFN posted gaap of 12.500/share. Meanwhile the lowest DFFN historical earnings result was in Q1 2019, when DFFN posted gaap of -40.500/share. Moving to Diffusion Pharmaceuticalss historical revenue numbers, the largest revenue quarter in our data set was seen in Q2 2023 when DFFN reported NA in revenue, while the smallest revenue quarter was Q2 2023 when DFFN reported NA in revenue.

For self directed investors doing their due diligence on DFFN or any other given stock, their research can benefit from looking into all of the Diffusion Pharmaceuticals historical earnings in our data set presented side by side on one page for ease of comparison. Reviewing this historical EPS information can help when projecting future earnings per share, as well as providing important context for pondering whether the historical earnings trajectory justifies the current stock value or not. That's why we bring you HistoricalEarnings.com to make it more convenient for investors to look into Diffusion Pharmaceuticals historical earnings, or the historical earnings information for any stock in our coverage universe. In your continued due diligence investigations, we hope you check out the further links included for historical PE studies, earnings surprises history as well as next earnings dates for DFFN. Thanks for visiting, and the next time you need to research DFFN historical earnings or those of another stock, we hope our site will come to your mind as your preferred historical earnings, revenue, and EPS research resource of choice.

Recommended: Lincoln National 13F Filers, ZEP Insider Buying, Top Ten Hedge Funds Holding DNUT.

 

DFFN Historical Earnings | www.HistoricalEarnings.com | Copyright © 2020 - 2023, All Rights Reserved

Nothing in HistoricalEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 7.8%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 7.8%.